Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Imatinib & Chronic myeloid leukemia / Chronic myelogenous leukemia (CML), the FDA first approved imatinib on May 10, 2001 for Chronic myeloid leukemia / Chronic myelogenous leukemia (CML) in blast crisis, accelerated phase, and chronic phase in adults (1)
The EMA (European Medicines Agency) has approved imatinib for Chronic myeloid leukemia / Chronic myelogenous leukemia (CML) in chronic, accelerated, and blast phases, as first‑line therapy and in previously treated patients, paralleling the FDA i…